Kevin Bitterman

Kevin Bitterman is a seasoned professional in the biotechnology and venture capital sectors, currently serving as a Partner at Atlas Venture since June 2017. Bitterman holds prominent board positions at several companies, including Chair of the Board at Chroma Medicine and membership on the boards of Remix Therapeutics, Kinaset Therapeutics, Disc Medicine, and Mariana Oncology. Additionally, Bitterman has contributed to the Isabella Stewart Gardner Museum's advisory board and served on the New England Venture Capital Association's board until August 2023. Academic credentials include a Ph.D. in Genetics from Harvard Medical School and a BA in Biology from Rutgers University.